Merrion Announces License Agreement with Novo Nordisk to Develop ... PharmaLive.com (press release), PA - Orazol (MER 101) is an oral bisphosphonate for oncology indications currently in Phase II development. This product aims to allow cancer patients with bone ... |
« ECO Animal Health makes headway in Japanese market - SmallCapNews.co.uk | Main | Monogram Announces Record Revenue for 2008, Guidance for Revenue ... - PharmaLive.com (press release) »
January 31, 2009
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00e54ed2f120883301116838c201970c
Listed below are links to weblogs that reference Merrion Announces License Agreement with Novo Nordisk to Develop ... - PharmaLive.com (press release):
Verify your Comment
Previewing your Comment
This is only a preview. Your comment has not yet been posted.
Your comment could not be posted. Error type:
Your comment has been posted. Post another comment
As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.
Having trouble reading this image? View an alternate.
Last articles
- Les nouveaux moteurs de la semaine : Rue des Professionnels, ReportLinker, Volti, Annuaire Entreprises, Jetcost et Wasalive (Abondance actu - vendredi 9 mars 2007)
- Reportlinker.com : un moteur de recherche d'études de marché.... - Le JP Blog - technoselect
- Reportlinker, lauréat de Tremplin Entreprises, 8 et 9 juilllet 2008, au Sénat, le premier événement du capital investissement en France
- Un moteur de recherche dédié aux études de marchés: Reportlinker
- Reportlinker, le moteur de recherche d'études de marché
- Sparus, Reportlinker et Quescom espoirs 2007 de l'IE-Club
- Reportlinker: L'IE-Club récompense les PME françaises innovantes
- Le prix IE-Club distingue les PME Kxen, Sparus Software et Reportlinker
- Présentation vidéo de Reportlinker
- Jeudi 2.0 : Recherche verticale ou méta recherche - Reportlinker
Comments